Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-02-22 @ 2:04 AM
Study NCT ID:
NCT02419469
Status:
TERMINATED
Last Update Posted:
2018-06-11
First Post:
2015-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Leukemia | View |
| None | Precursor-B acute lymphoblastic leukemia | View |
| None | ALL | View |
| None | Lymphoblastic lymphoma | View |
| None | LL | View |
| None | Lymphoma | View |
| None | Cytarabine | View |
| None | Ara-C | View |
| None | Cytosar | View |
| None | DepoCyt | View |
| None | Cytosine Arabinosine Hydrochloride | View |
| None | Daunorubicin | View |
| None | Daunorubicin Hydrochloride | View |
| None | Cerubidine | View |
| None | Daunomycin | View |
| None | DNR | View |
| None | Vincristine | View |
| None | Prednisone | View |
| None | PEG asparaginase | View |
| None | Pegaspargase | View |
| None | Oncaspar | View |
| None | Polyethylene glycol conjugated lasparaginase-H | View |
| None | Ofatumumab | View |
| None | Arzerra | View |
| None | Rituximab | View |
| None | Rituxan | View |
| None | Methotrexate | View |
| None | Cyclophosphamide | View |
| None | Cytoxan | View |
| None | Neosar | View |
| None | Mercaptopurine | View |
| None | 6-mercaptopurine | View |
| None | Purinethol | View |
| None | 6-MP | View |
| None | Doxorubicin | View |
| None | Doxorubicin hydrochloride | View |
| None | Adriamycin PFS | View |
| None | Adriamycin RDF | View |
| None | Adriamycin | View |
| None | Rubex | View |
| None | Dexamethasone | View |
| None | Decadron | View |
| None | Thioguanine | View |
| None | 6-thioguanine | View |